Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Symrise AG
  6. News
  7. Summary
    SY1   DE000SYM9999


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Symrise : continues its robust course of growth

10/29/2020 | 05:05am EDT

Symrise AG successfully continued its profitable growth course in the third quarter despite the global coronavirus pandemic. In an economically challenging and heterogeneous market envi-ronment, the Group increased its sales in the first nine months of 2020 by 5.9 % to € 2,703 million (9M 2019: € 2,551 million). In organic terms - i.e. excluding the portfolio effect of ADF/IDF and cur-rency translation effects - sales were up by 3.3 % in the first nine months. All segments contribut-ed to this positive development and achieved organic sales growth.

'Thanks to our solid positioning, the broadly diversified product portfolio, and the commitment and flexibility of our employees, we were able to build on the previous months and further increase our sales, also during the global coronavirus pandemic. The shifts in consumer demand during the first six months of the year have continued during the third quarter. Product solutions for food as well as per-sonal care and hygiene remained in high demand, while demand for luxury items such as fine fragranc-es was less,' said Dr Heinz-Jürgen Bertram, CEO of Symrise AG. 'We are overall confident that we will conclude this historically very special year with good growth.'

Scent & Care with strong growth in Personal Care, Oral Care and Menthol

Scent & Care, the business with fragrances, cosmetic ingredients and aroma molecules, achieved good organic sales growth of 3.1 % in the first nine months. Sales increased by 4.0 % in the third quarter. Taking currency translation effects into account, sales amounted to € 1,057 million and were slightly lower than in the prior year period (9M 2019: € 1,070 million).

Sales in the Fragrance division continued to be driven by Consumer Fragrance and Oral Care due to strong consumer demand for personal care and hygiene products. Both areas achieved organic growth in the double-digit percentage range. The Fine Fragrance unit continued to be affected by the corona-virus pandemic. On the other hand, in the third quarter North America in particular saw better project vitality with major customers related to luxury items. Overall, the Fragrance division achieved solid or-ganic growth in the single-digit percentage range, with growth in all regions.

Sales in the Aroma Molecules division were characterized by lower demand for fragrance solutions on one hand and very positive momentum with menthol activities on the other. Due to capacity expan-sions, the Menthol business unit achieved double-digit growth. The EAME and the North and Latin America regions achieved strongest growth. Sales in the Aroma Molecules division were at large slightly below the high level of the previous year.

The Cosmetic Ingredients division was impacted by reduced travel activity due to the coronavirus pan-demic, which led to lower demand for sun protection products. The other application areas achieved good organic growth in the single and double-digit percentage range. The Latin and North American regions, and above all the national markets of Brazil, Canada, the USA and Mexico, were the main growth drivers. Overall, sales in the Cosmetic Ingredients division were slightly below the strong prior year results.

Flavor driven by trend toward cooking and eating at home

In the Flavor segment, which comprises solutions for food and beverages, changes in consumer be-haviour due to the coronavirus pandemic continued throughout the third quarter. The trend toward cook-ing and eating at home remained strong, resulting in strong demand for products from the Savory busi-ness unit and product solutions for baked goods and cereals. At the same time, reduced out-of-home eating and drinking further affected demand for beverage products and sweets. The segment achieved organic growth of 0.6 % in the first nine months as well as in the third quarter. Segment sales in report-ing currency amounted to € 949 million (9M 2019: € 966 million).

Sales in the EAME region were characterized by a significantly reduced demand for beverage products and sweets. At the same time, Savory achieved high single-digit growth. Product innovations for alter-native proteins developed particularly well. The national markets of Germany and Russia achieved strongest growth. The pandemic continued to have a more negative impact on demand in France and the UK. Overall, sales in EAME were slightly below the result of the first nine month of the prior year.

In North America, Flavor achieved double-digit sales growth on an organic basis in the third quarter. As a result, the segment achieved a solid single-digit organic growth rate in the first nine months. Custom-ers particularly demanded solutions for beverage and savory products.

Asia/Pacific reported strong demand for savory applications, which achieved organic growth in the double-digit percentage range. The largest increases were achieved in Indonesia, Thailand, Vietnam and South Korea. Sales for beverage and sweet applications were slower, particularly in the third quarter. In total, organic sales in the region were at the prior year level.

The segment achieved strongest growth in Latin America in the first nine months of 2020 and remained largely unaffected by the coronavirus pandemic. All business units realized high organic growth in the single or double-digit percentage range. The national markets of Brazil, Uruguay and Mexico developed particularly well.

Nutrition with strong growth in Pet Food

The Nutrition segment, which includes the food, pet food and probiotics applications of Diana as well as the activities of ADF/IDF, achieved strong organic sales growth of 9.1 %. Growth in the third quarter amounted to 6.1 %. Sales in the reporting currency amounted to € 697 million which represents an in-crease of 35.1 % (9M 2019: € 516 million) year on year. In the reporting period, ADF/IDF contributed € 156 million.

Pet Food continued to be the growth driver of the segment with strong organic growth in the single or double-digit percentage range in all regions. Sales developed particularly dynamically in the USA, Mex-ico, Brazil and South Korea.

In the Food unit, the Asia/Pacific region reported single-digit organic growth, with particularly strong dynamics in China, India, South Korea and Taiwan. In EAME, sales slightly exceeded the prior year level, while North America and Latin America were just below it. Overall, the coronavirus pandemic dampened business performance in numerous submarkets, with out-of-home consumption largely be-low prior year.

The business of US-based ADF/IDF, which was acquired in November 2019, developed well and ex-ceeded expectations. In this area, the segment benefited from increased demand as a result of the pandemic.

The Probiotics business unit, which is part of Probi, had a very good third quarter and achieved organic sales growth in the double-digit percentage range in the first nine months. Growth was particularly driv-en by strong results in the North America region.

Symrise remains confident about the remaining months of the current financial year and reaffirms sales and earnings targets

Also with the ongoing coronavirus pandemic, Symrise continues to be fully operational worldwide and provides customers with reliable supply. With its global presence, its steadily growing and diversified portfolio and its broad customer base, the Group considers itself to be robust and securely positioned even in the current challenging market environment.

For 2020, Symrise expects organic growth of 3 to 4 % which would be above market growth. Estimates expect market growth of up to 3 % in the current environment.

Based on the continuing strong business performance, the Group is confirming an EBITDA margin in the range of 21 to 22 % for the 2020 fiscal year.

The medium-term targets remain fully intact. The Company aims to increase its annual sales to € 5.5 to € 6.0 billion by the end of 2025. Symrise wants to achieve this with annual organic growth of 5 to 7 % (CAGR) as well as additional targeted acquisitions. In the medium term, profitability should remain with-in a target corridor of 20 to 23 %.

Financial calendar 2021
11 March
Full Year Results 2020

28 April
Interim Group Report January - March 2021 (trading update)

6 May
Annual General Meeting



Symrise AG published this content on 29 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 October 2020 10:04:11 UTC

ę Publicnow 2020
All news about SYMRISE AG
08:58aSymrise launches SymProBiome, a platform with disruptive innovations in microbiome rese..
08:29aSYMRISE AG : Warburg Research remains Neutral
07:50aSYMRISE AG : Deutsche Bank gives a Buy rating
06:26aSYMRISE AG : JP Morgan reaffirms its Neutral rating
10/26SYMRISE AG : DZ Bank sticks Neutral
10/26GLOBAL MARKETS LIVE : Michelin, Facebook, UBS, Tesla, Volvo...
10/26Symrise AG english
10/26SYMRISE AG : Goldman Sachs reiterates its Buy rating
10/26SYMRISE AG : Kepler Cheuvreux reiterates its Buy rating
10/26SYMRISE AG : UBS reaffirms its Buy rating
More news
Analyst Recommendations on SYMRISE AG
More recommendations
Sales 2021 3 798 M 4 406 M 4 406 M
Net income 2021 372 M 431 M 431 M
Net Debt 2021 1 081 M 1 255 M 1 255 M
P/E ratio 2021 44,6x
Yield 2021 0,91%
Capitalization 17 708 M 20 521 M 20 546 M
EV / Sales 2021 4,95x
EV / Sales 2022 4,61x
Nbr of Employees 10 812
Free-Float 94,9%
Duration : Period :
Symrise AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYMRISE AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 120,15 €
Average target price 119,69 €
Spread / Average Target -0,38%
EPS Revisions
Managers and Directors
Heinz-JŘrgen Bertram Chief Executive Officer
Olaf Klinger Chief Financial Officer
Michael K÷nig Chairman-Supervisory Board
Horst-Otto Gerberding Member-Supervisory Board
Peter Winkelmann Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
SYMRISE AG10.84%20 198
ECOLAB INC.6.43%65 880
SIKA AG28.33%47 801
GIVAUDAN SA16.43%43 551